Evaluation of outcomes and genetic predictive factors for prognosis and toxicity in hormone-refractory prostate cancer patients following combination therapy with docetaxel, estramustine, and carboplatin
Evaluation of outcomes and genetic predictive factors for prognosis and toxicity in hormone-refractory prostate cancer patients following combination therapy with docetaxel, estramustine, and carboplatin
复制标题
多西他赛、雌莫司汀和卡铂联合治疗后激素难治性前列腺癌患者预后和毒性的结果和遗传预测因素的评估
DOI：
--
复制
发表时间：
2009
期刊：
影响因子：
--
通讯作者：
et al.
中科院分区：
文献类型：
--
作者：
Narita S;et al.
